Unknown

Dataset Information

Interleukin-18 in patients with acute coronary syndromes.


ABSTRACT:

Background

We aimed to assess associations between circulating IL-18 concentrations and cardiovascular outcomes in patients with acute coronary syndromes (ACS).

Hypothesis and methods

Plasma IL-18 concentrations were measured at admission, discharge, 1 month, and 6 months in patients with ACS in the PLATelet inhibition and patient Outcomes (PLATO) trial. Associations with outcomes were evaluated with Cox regression models on the composite of CV death, spontaneous myocardial infarction (sMI), or stroke; and on CV death or sMI separately, including adjustment for clinical risk factors and biomarkers (cTnT-hs, NT-proBNP, cystatin C, CRP-hs, and GDF-15).

Results

Median IL-18 concentrations at baseline, discharge, 1 month, and 6 months were 237, 283, 305, and 320 ng/L (n =

SUBMITTER: Akerblom A 

PROVIDER: S-EPMC6906991 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature